21-200-318

Roche Diagnostics cobas™ Liat SARS-CoV-2, Influenza A/B and RSV Control Kit

Manufacturer: Roche Diagnostics

Select a Size

Pack Size SKU Availability Price
Each of 1 21-200-318-Each-of-1 In Stock ₹ 16,085.28

21-200-318 - Each of 1

₹ 16,085.28

In Stock

Quantity

1

Base Price: ₹ 16,085.28

GST (18%): ₹ 2,895.35

Total Price: ₹ 18,980.63

Content And Storage

20 Tests/Kit; Store at 2°C to 8°C

CPT Code

87637

Clia Complexity

Waived (EUA)

Detection Method

Nucleic Acid RT-PCR

Format

Kit

Sensitivity

Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement

Disposable

Single-use

For Use With (Equipment)

Used with the cobas™ liat analyzer

Quantity

1

Test Time

20 min.

Dimensions (L x W x H)

10.6 x 6.5 x 5.4 in.

Form

Ready-to-Use (RTU)

Control Sets

integrated sample processing control, positive and negative controls

CE Marker

Yes

Detectable Analytes

SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies

DoA Calibrators

No

Sample Type

Nasaopharyngeal or anterior nasal

Type

Test

For Use With (Application)

Detection of SARS-CoV-2, Influenza A/B, and RSV

Product Line

cobas™

Specificity

SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement

Analysis Time

20 min.

Weight (English)

2.4 lb.

Related Products

Img

Roche Diagnostics

21-200-319

--

Img

Roche Diagnostics

23-312-207

--

Img

Roche Diagnostics

23-312-200

--

Img

Germaine™ Laboratories

23-900-207

--

Img

Germaine™ Laboratories

23-111-441

--

Img

Roche Diagnostics

23-312-208

--

Img

Fischer Scientific

23-999-117

--

Img

Fischer Scientific

23-999-116

--

Description

  • The cobas™ liat SARS-CoV-2, Influenza A/B and RSV control kit for use with the cobas liat SARS-CoV-2, Influenza A/B and RSV assay
  • Control kit includes three positive and three negative controls.

SAFETY INFORMATION

  • ShelfLife : 12 Months

Compare Similar Items

Show Difference

Img

Roche Diagnostics

21-200-318

--


Content And Storage:
20 Tests/Kit; Store at 2°C to 8°C

CPT Code:
87637

Clia Complexity:
Waived (EUA)

Detection Method:
Nucleic Acid RT-PCR

Format:
Kit

Sensitivity:
Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement

Disposable:
Single-use

For Use With (Equipment):
Used with the cobas™ liat analyzer

Quantity:
1

Test Time:
20 min.

Dimensions (L x W x H):
10.6 x 6.5 x 5.4 in.

Form:
Ready-to-Use (RTU)

Control Sets:
integrated sample processing control, positive and negative controls

CE Marker:
Yes

Detectable Analytes:
SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies

DoA Calibrators:
No

Sample Type:
Nasaopharyngeal or anterior nasal

Type:
Test

For Use With (Application):
Detection of SARS-CoV-2, Influenza A/B, and RSV

Product Line:
cobas™

Specificity:
SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement

Analysis Time:
20 min.

Weight (English):
2.4 lb.

Img

Roche Diagnostics

21-200-319

--


Content And Storage:
3 sets of positive and negative controls per kit

CPT Code:
87637 (for assay)

Clia Complexity:
Waived (EUA)

Detection Method:
RT-PCR

Format:
Kit

Sensitivity:
For assay: Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement

Disposable:
Single-use

For Use With (Equipment):
Used with the cobas™ liat analyzer to validate lots or run control tests

Quantity:
1

Test Time:
__

Dimensions (L x W x H):
6.1 x 10 x 1.4 in.

Form:
Ready-to-Use (RTU)

Control Sets:
integrated sample processing control, positive and negative controls

CE Marker:
Yes

Detectable Analytes:
SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies

DoA Calibrators:
No

Sample Type:
For assay: nasaopharyngeal or anterior nasal

Type:
Control

For Use With (Application):
Detection of SARS-CoV-2, Influenza A/B, and RSV

Product Line:
cobas™

Specificity:
For assay: SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement

Analysis Time:
20 min.

Weight (English):
0.1 lb.

Img

Mopec

21-200-323

--


Content And Storage:
__

CPT Code:
__

Clia Complexity:
__

Detection Method:
__

Format:
__

Sensitivity:
__

Disposable:
__

For Use With (Equipment):
__

Quantity:
__

Test Time:
__

Dimensions (L x W x H):
__

Form:
__

Control Sets:
__

CE Marker:
__

Detectable Analytes:
__

DoA Calibrators:
__

Sample Type:
__

Type:
__

For Use With (Application):
__

Product Line:
__

Specificity:
__

Analysis Time:
__

Weight (English):
__

Img

Fischer Scientific

21-200-340

--


Content And Storage:
__

CPT Code:
__

Clia Complexity:
__

Detection Method:
__

Format:
__

Sensitivity:
__

Disposable:
__

For Use With (Equipment):
__

Quantity:
__

Test Time:
__

Dimensions (L x W x H):
__

Form:
__

Control Sets:
__

CE Marker:
__

Detectable Analytes:
__

DoA Calibrators:
__

Sample Type:
__

Type:
__

For Use With (Application):
__

Product Line:
__

Specificity:
__

Analysis Time:
__

Weight (English):
__